Lutron Recalls Power Interfaces for LED Tape Lights Due to Shock Hazard
No injuries reported. This is a preventive recall action.
Lutron Recalls Power Interfaces for LED Tape Lights Due to Shock Hazard
Lutron Electronics Co. Inc., of Coopersburg, Pennsylvania · Lutron-branded power interfaces for LED tape lights




Product Description
This recall involves Lutron-branded power interfaces, model LU-PH3-B, intended for use with LED tape lights. The 96W hard-wired power interfaces were distributed alone and as part of Lumaris RGB+ tunable white LED tape light starter kits for RadioRA 3 systems (model RRL-MTK-RT-IN) and HomeWorks systems (model HWL-MTK-RT-IN).
Hazard
The power interface can fail during a significant power surge (e.g., lightning strike), posing a shock hazard to consumers if they touch the LED tape lights.
Remedy
Consumers should immediately stop using the recalled power interfaces and any connected lighting and turn off the power at the circuit breaker. Consumers should contact Lutron for instructions on how to receive their free replacement power interface and how it will be installed at no charge. Consumers should go to https://residential.lutron.com/us/en/safety/safety-recall to determine if their unit is included in this recall and, if so, to register to receive installation of the replacement power interface. If a unit is included, Lutron will provide the free replacement power interface and a pre-paid mailing label that the consumer can use to return the unit to Lutron.
411 Press Analysis
Lutron Electronics Co. Inc., of Coopersburg, Pennsylvania has voluntarily recalled about 1,944 of Lutron-branded power interfaces for LED tape lights as a preventive safety measure. The recall was announced by the CPSC on June 5, 2025. The power interface can fail during a significant power surge (e.g., lightning strike), posing a shock hazard to consumers if they touch the LED tape. While no injuries have been reported, the identified hazard warrants consumer attention. Affected consumers should receive a free replacement. The CPSC recommends discontinuing use of the product until the remedy has been completed.